Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise.

about

Shared decision making in the treatment of stage I non small cell lung cancer-a choice which should equally involve both sides

P2860

Q42359042-05ED7E2C-9EBA-4300-B58A-7D1EC4078E49

P2860

Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise.

Item

http://www.wikidata.org/entity/Q42354883

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Surgery versus SABR for early ...... he moving target of equipoise.

@en

Surgery versus SABR for early ...... he moving target of equipoise.

@nl

type

Item

label

Surgery versus SABR for early ...... he moving target of equipoise.

@en

Surgery versus SABR for early ...... he moving target of equipoise.

@nl

prefLabel

Surgery versus SABR for early ...... he moving target of equipoise.

@en

Surgery versus SABR for early ...... he moving target of equipoise.

@nl

P1476

Surgery versus SABR for early ...... he moving target of equipoise.

@en

P2093

Alexander V Louie

http://www.w3.org/2001/XMLSchema#string

Hanbo Chen

http://www.w3.org/2001/XMLSchema#string

Houda Bahig

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults

Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.

Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly

Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.

P304

953-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2017.03.80

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28523146

http://www.w3.org/2001/XMLSchema#string

P932

5418272

http://www.w3.org/2001/XMLSchema#string

Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise.

about

P2860

P2860

Surgery versus SABR for early stage non-small cell lung cancer: the moving target of equipoise.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932